IBD | Control | |
---|---|---|
No. of patients (CD/UC) | 102 (49/53) | 23 |
No. of biopsies (CD/UC) | 193 (97/96) | 43 |
Males/females/unknown | 40/61/1 | 7/16/0 |
Average age (S.D.) (years) | 48 (15) | 60 (10) |
Average BMI (S.D.) (kg/m2) | 24.9 (5.0) | 24.0 (4.0) |
No. of patients receiving therapy | ||
Steroids | 28 | 0 |
Azathioprine | 17 | 0 |
Mesalazine | 29 | 0 |
None | 29 | 19 |
Other | 36 | 4 |
Smokers/nonsmokers/unknown | 26/64/12 | |
Patients in remission | 29 | |
Inflamed/noninflamed (biopsies total) | 73/120 | |
Inflamed/noninflamed (paired biopsies) | 53/53 | |
Patients excluded | 0 | 0 |